Vaccines are a hot area of development and investment, spurred by renewed awareness of the critical public health role they play and the enormous commercial success of the COVID-19 vaccines that have reached the market. Leaders at the Biotechnology Innovation Organization annual meeting agreed there is renewed interest in the field from a wide range of industry stakeholders as the COVID-19 pandemic has reset the outlook for the business area.
"I probably went two to three years without seeing a vaccines business plan. I'm probably seeing two to three a...






